France vs Pre-demographic dividend: Immunization, measles second dose
France
93.0%
in 2024
Pre-demographic dividend
50.4%
in 2024
France rank
45th
Pre-demographic dividend rank
42nd
Immunization, measles second dose over time
- France
- Pre-demographic dividend
How they compare
France currently reports 93.0% against 50.4% in Pre-demographic dividend, a difference of 42.6%.
That makes France's figure about 1.8 times Pre-demographic dividend's.
Across all 15 years both countries report, France has been ahead every year.
France ranks 45th and Pre-demographic dividend ranks 42nd of 178 countries.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Pre-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76.0% | 14.9% | 61.1% | France |
| 2020s | 92.2% | 40.9% | 51.3% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, France or Pre-demographic dividend?
- France, at 93.0% against 50.4% in Pre-demographic dividend as of 2024.
- What is the difference in immunization, measles second dose between France and Pre-demographic dividend?
- 42.6%, with France ahead.
- How many years of comparable data are there for France and Pre-demographic dividend?
- 15 years are reported by both, from 2010 to 2024.
- How do France and Pre-demographic dividend rank globally for immunization, measles second dose?
- France ranks 45th and Pre-demographic dividend ranks 42nd of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.